| Mr William Raul Echevarria, LPC-IT; SAC-IT, MS | |
|
2222 S 114th St, West Allis, WI 53227-1031 | |
| (414) 449-4444 | |
| Not Available |
| Full Name | Mr William Raul Echevarria |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 2222 S 114th St, West Allis, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801228705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 18785-130 (Wisconsin) | Secondary |
| 101YP2500X | Counselor - Professional | 4110-226 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr William Raul Echevarria, LPC-IT; SAC-IT, MS 1610 Miller Park Way, Milwaukee, WI 53214-3604 Ph: (414) 672-3801 | Mr William Raul Echevarria, LPC-IT; SAC-IT, MS 2222 S 114th St, West Allis, WI 53227-1031 Ph: (414) 449-4444 |
News Archive
A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists led by David Kahler, PhD, NYSCF Director of Laboratory Automation, have developed a new way to generate induced pluripotent stem (iPS) cell lines from human fibroblasts, acquired from both healthy and diseased donors.
Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation.
More than 2 million procedures every year take place around the world to heal bone fractures and defects from trauma or disease, making bone the second most commonly transplanted tissue after blood.
elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.
› Verified 4 days ago
Nicholas Paul Hayon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10201 W Lincoln Ave, Suite 102, West Allis, WI 53227 Phone: 414-546-6880 Fax: 414-546-6891 | |
Lashawna Thomas, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 Fax: 262-643-4617 | |
Ashley A Mitchell, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 | |
Charity Walsh, LPC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 S 70th St, Ste 301, West Allis, WI 53214 Phone: 414-475-2788 | |
Mr. Christian Lamarr Lemmie, LPC, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2424 S 102nd St, West Allis, WI 53227 Phone: 414-203-4514 | |
Nicole F Jensen, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2424 S 90th St, West Allis, WI 53227 Phone: 414-773-4312 Fax: 414-329-5637 | |
Grace Ellul, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10150 W National Ave Ste 390, West Allis, WI 53227 Phone: 414-545-4430 |